{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:41Z","timestamp":1792785041048,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":140,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Graduate Innovation Project of Central South University","award":["2023ZZTS0989"],"award-info":[{"award-number":["2023ZZTS0989"]}],"id":[{"id":"https:\/\/ror.org\/00f1zfq44","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the National Natural Science Foundation of China","award":["82372934"],"award-info":[{"award-number":["82372934"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the science and technology innovation Program of Hunan Province","award":["2023RC3077"],"award-info":[{"award-number":["2023RC3077"]}]},{"name":"the National Key Research and Development Program of China","award":["2022YFC2504700"],"award-info":[{"award-number":["2022YFC2504700"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44307-9","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:14:49Z","timestamp":1777659289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BLK suppresses melanoma progression and improves prognosis via pyroptosis regulation"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhe","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"10400","key":"44307_CR1","first-page":"485","volume":"402","author":"GV Long","year":"2023","unstructured":"Long, G. V., Swetter, S. M., Menzies, A. M., Gershenwald, J. E. & Scolyer, R. A. Cutan. melanoma Lancet, 402(10400), 485\u2013502. (2023).","journal-title":"Cutan. melanoma Lancet"},{"key":"44307_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semcancer.2019.08.002","volume":"59","author":"M Marzagalli","year":"2019","unstructured":"Marzagalli, M., Ebelt, N. D. & Manuel, E. R. Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment. Semin Cancer Biol. 59, 236\u2013250 (2019).","journal-title":"Semin Cancer Biol."},{"issue":"11","key":"44307_CR3","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19(11), 1423\u20131437 (2013).","journal-title":"Nat. Med."},{"issue":"10","key":"44307_CR4","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1038\/s41418-023-01219-9","volume":"30","author":"Z Kuang","year":"2023","unstructured":"Kuang, Z. et al. USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1. Cell. Death Differ. 30(10), 2249\u20132264 (2023).","journal-title":"Cell. Death Differ."},{"issue":"1","key":"44307_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-020-01786-6","volume":"40","author":"W Fang","year":"2021","unstructured":"Fang, W. et al. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8(+) T cell exclusion. J. Exp. Clin. Cancer Res. 40(1), 4 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"44307_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2024.01.008","volume":"187","author":"G Leuzzi","year":"2024","unstructured":"Leuzzi, G. et al. SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion. Cell 187(4), 861\u2013881e32 (2024).","journal-title":"Cell"},{"issue":"11","key":"44307_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.trecan.2023.07.015","volume":"9","author":"JH Kang","year":"2023","unstructured":"Kang, J. H. & Zappasodi, R. Modulating Treg stability to improve cancer immunotherapy. Trends Cancer. 9(11), 911\u2013927 (2023).","journal-title":"Trends Cancer"},{"issue":"6","key":"44307_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","volume":"40","author":"H Huang","year":"2022","unstructured":"Huang, H. et al. Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer. Cancer Cell. 40(6), 656\u2013673 (2022). e7.","journal-title":"Cancer Cell."},{"issue":"3","key":"44307_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1053\/j.gastro.2023.05.030","volume":"165","author":"KP Ko","year":"2023","unstructured":"Ko, K. P. et al. Key genetic determinants driving esophageal squamous cell carcinoma initiation and immune evasion. Gastroenterology 165(3), 613\u2013628e20 (2023).","journal-title":"Gastroenterology"},{"issue":"11","key":"44307_CR10","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/cac2.12607","volume":"44","author":"J Cai","year":"2024","unstructured":"Cai, J. et al. Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma. Cancer Commun. (Lond). 44(11), 1231\u20131260 (2024).","journal-title":"Cancer Commun. (Lond)"},{"issue":"7","key":"44307_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1056\/NEJMoa1904059","volume":"381","author":"C Robert","year":"2019","unstructured":"Robert, C. et al. Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma. N Engl. J. Med. 381(7), 626\u2013636 (2019).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"44307_CR12","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1038\/s41467-023-40994-4","volume":"14","author":"TMR Noviello","year":"2023","unstructured":"Noviello, T. M. R. et al. Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial. Nat. Commun. 14(1), 5914 (2023).","journal-title":"Nat. Commun."},{"issue":"4","key":"44307_CR13","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/annonc\/mdz011","volume":"30","author":"O Hamid","year":"2019","unstructured":"Hamid, O. et al. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. Ann. Oncol. 30(4), 582\u2013588 (2019).","journal-title":"Ann. Oncol."},{"issue":"1","key":"44307_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","volume":"8","author":"Q Sun","year":"2023","unstructured":"Sun, Q. et al. Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends. Signal. Transduct. Target. Ther. 8(1), 320 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"44307_CR15","doi-asserted-by":"publisher","first-page":"1490129","DOI":"10.3389\/fimmu.2024.1490129","volume":"15","author":"D Zhang","year":"2024","unstructured":"Zhang, D., Zhao, J., Zhang, Y., Jiang, H. & Liu, D. Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity. Front. Immunol. 15, 1490129 (2024).","journal-title":"Front. Immunol."},{"issue":"1","key":"44307_CR16","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1038\/s41467-024-47425-y","volume":"15","author":"M Lauss","year":"2024","unstructured":"Lauss, M. et al. Molecular patterns of resistance to immune checkpoint blockade in melanoma. Nat. Commun. 15(1), 3075 (2024).","journal-title":"Nat. Commun."},{"key":"44307_CR17","doi-asserted-by":"crossref","unstructured":"Hossain, S. M., Ly, K., Sung, Y. J., Braithwaite, A. & Li, K. Immune checkpoint inhibitor therapy for metastatic melanoma: What should we focus on to improve the clinical outcomes? Int. J. Mol. Sci. 25(18) (2024).","DOI":"10.3390\/ijms251810120"},{"key":"44307_CR18","doi-asserted-by":"publisher","first-page":"847345","DOI":"10.3389\/fimmu.2022.847345","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Programmed cell death tunes tumor immunity. Front. Immunol. 13, 847345. (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"44307_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13046-024-03089-6","volume":"43","author":"L Gao","year":"2024","unstructured":"Gao, L., Shay, C. & Teng, Y. Cell death shapes cancer immunity: Spotlighting PANoptosis. J. Exp. Clin. Cancer Res. 43(1), 168 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"18","key":"44307_CR20","doi-asserted-by":"publisher","first-page":"8813","DOI":"10.7150\/thno.62521","volume":"11","author":"SK Hsu","year":"2021","unstructured":"Hsu, S. K. et al. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment. Theranostics 11(18), 8813\u20138835 (2021).","journal-title":"Theranostics"},{"issue":"1","key":"44307_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13046-021-02065-8","volume":"40","author":"R Loveless","year":"2021","unstructured":"Loveless, R., Bloomquist, R. & Teng, Y. Pyroptosis at the forefront of anticancer immunity. J. Exp. Clin. Cancer Res. 40(1), 264 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"44307_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu, P. et al. Pyroptosis: mechanisms and diseases. Signal. Transduct. Target. Ther. 6(1), 128 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"44307_CR23","doi-asserted-by":"crossref","unstructured":"Wang, J. L. et al. Pyroptosis and inflammasomes in cancer and inflammation. MedComm (2020). 4(5), e374 (2023).","DOI":"10.1002\/mco2.374"},{"issue":"1","key":"44307_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13045-024-01545-6","volume":"17","author":"S Zhou","year":"2024","unstructured":"Zhou, S., Liu, J., Wan, A., Zhang, Y. & Qi, X. Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis. J. Hematol. Oncol. 17(1), 22 (2024).","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"44307_CR25","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41419-023-06382-y","volume":"14","author":"Y Hu","year":"2023","unstructured":"Hu, Y. et al. The multifaceted roles of GSDME-mediated pyroptosis in cancer: Therapeutic strategies and persisting obstacles. Cell. Death Dis. 14(12), 836 (2023).","journal-title":"Cell. Death Dis."},{"issue":"1","key":"44307_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40164-023-00464-5","volume":"12","author":"M Li","year":"2023","unstructured":"Li, M. et al. The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment. Exp. Hematol. Oncol. 12(1), 103 (2023).","journal-title":"Exp. Hematol. Oncol."},{"issue":"3\u20134","key":"44307_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s10495-019-01515-1","volume":"24","author":"CC Zhang","year":"2019","unstructured":"Zhang, C. C. et al. Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3\/GSDME activation. Apoptosis 24(3\u20134), 312\u2013325 (2019).","journal-title":"Apoptosis"},{"key":"44307_CR28","doi-asserted-by":"publisher","first-page":"129674","DOI":"10.1016\/j.bmcl.2024.129674","volume":"102","author":"R Kohal","year":"2024","unstructured":"Kohal, R. et al. Fyn, Blk, and Lyn kinase inhibitors: A mini-review on medicinal attributes, research progress, and future insights. Bioorg. Med. Chem. Lett. 102, 129674 (2024).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"44307_CR29","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1128\/MCB.20.4.1227-1233.2000","volume":"20","author":"G Texido","year":"2000","unstructured":"Texido, G. et al. The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation. Mol. Cell. Biol. 20(4), 1227\u20131233 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"44307_CR30","doi-asserted-by":"publisher","first-page":"114051","DOI":"10.1016\/j.ejmech.2021.114051","volume":"229","author":"T Fu","year":"2022","unstructured":"Fu, T., Zuo, Y., Zhong, Z., Chen, X. & Pan, Z. Discovery of selective irreversible inhibitors of B-Lymphoid tyrosine kinase (BLK). Eur. J. Med. Chem. 229, 114051 (2022).","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"44307_CR31","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/s41375-019-0682-7","volume":"34","author":"E Kim","year":"2020","unstructured":"Kim, E. et al. The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironment. Leukemia 34(6), 1588\u20131598 (2020).","journal-title":"Leukemia"},{"issue":"2","key":"44307_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10753-020-01355-1","volume":"44","author":"X Zhang","year":"2021","unstructured":"Zhang, X., Mei, D., Zhang, L. & Wei, W. Src family protein kinase controls the fate of B cells in autoimmune diseases. Inflammation 44(2), 423\u2013433 (2021).","journal-title":"Inflammation"},{"issue":"11","key":"44307_CR33","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.cellsig.2014.07.008","volume":"26","author":"RA Bartolome","year":"2014","unstructured":"Bartolome, R. A. et al. A Blk-p190RhoGAP signaling module downstream of activated Galpha13 functionally opposes CXCL12-stimulated RhoA activation and cell invasion. Cell. Signal. 26(11), 2551\u20132561 (2014).","journal-title":"Cell. Signal."},{"key":"44307_CR34","doi-asserted-by":"publisher","first-page":"101671","DOI":"10.1016\/j.tranon.2023.101671","volume":"33","author":"Y Xu","year":"2023","unstructured":"Xu, Y. et al. Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression. Transl Oncol. 33, 101671 (2023).","journal-title":"Transl Oncol."},{"issue":"1","key":"44307_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41389-023-00504-z","volume":"13","author":"JW Magrath","year":"2024","unstructured":"Magrath, J. W. et al. Transcriptomic analysis identifies B-lymphocyte kinase as a therapeutic target for desmoplastic small round cell tumor cancer stem cell-like cells. Oncogenesis 13(1), 2 (2024).","journal-title":"Oncogenesis"},{"issue":"5","key":"44307_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4132\/jptm.2022.07.26","volume":"56","author":"S Choi","year":"2022","unstructured":"Choi, S. et al. Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma. J. Pathol. Transl Med. 56(5), 281\u2013288 (2022).","journal-title":"J. Pathol. Transl Med."},{"issue":"8","key":"44307_CR37","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ng.2350","volume":"44","author":"H Zhang","year":"2012","unstructured":"Zhang, H. et al. The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells. Nat. Genet. 44(8), 861\u2013871 (2012).","journal-title":"Nat. Genet."},{"issue":"13","key":"44307_CR38","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.7150\/ijbs.86855","volume":"19","author":"H Huang","year":"2023","unstructured":"Huang, H. et al. Molecular mechanisms of pyroptosis and its role in anti-tumor immunity. Int. J. Biol. Sci. 19(13), 4166\u20134180 (2023).","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"44307_CR39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","volume":"48","author":"J Xu","year":"2023","unstructured":"Xu, J. & Nunez, G. The NLRP3 inflammasome: activation and regulation. Trends Biochem. Sci. 48(4), 331\u2013344 (2023).","journal-title":"Trends Biochem. Sci."},{"issue":"7575","key":"44307_CR40","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526(7575), 666\u2013671 (2015).","journal-title":"Nature"},{"issue":"Pt 2","key":"44307_CR41","doi-asserted-by":"publisher","first-page":"124832","DOI":"10.1016\/j.ijbiomac.2023.124832","volume":"242","author":"AA Bhat","year":"2023","unstructured":"Bhat, A. A. et al. The pyroptotic role of Caspase-3\/GSDME signalling pathway among various cancer: A Review. Int. J. Biol. Macromol. 242(Pt 2), 124832 (2023).","journal-title":"Int. J. Biol. Macromol."},{"issue":"7876","key":"44307_CR42","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-021-03875-8","volume":"597","author":"S Lee","year":"2021","unstructured":"Lee, S. et al. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature 597(7876), 415\u2013419 (2021).","journal-title":"Nature"},{"key":"44307_CR43","doi-asserted-by":"crossref","unstructured":"Qi, Z., Zhu, L., Wang, K. & Wang, N. PANoptosis: Emerging mechanisms and disease implications. Life Sci. 333, 122158 (2023).","DOI":"10.1016\/j.lfs.2023.122158"},{"issue":"1","key":"44307_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/jcmm.17061","volume":"26","author":"B Chao","year":"2022","unstructured":"Chao, B. et al. Predicting the prognosis of glioma by pyroptosis-related signature. J. Cell. Mol. Med. 26(1), 133\u2013143 (2022).","journal-title":"J. Cell. Mol. Med."},{"key":"44307_CR45","doi-asserted-by":"publisher","first-page":"852734","DOI":"10.3389\/fbioe.2022.852734","volume":"10","author":"Z Gong","year":"2022","unstructured":"Gong, Z. et al. Identification of a pyroptosis-related gene signature for predicting the immune status and prognosis in lung adenocarcinoma. Front. Bioeng. Biotechnol. 10, 852734 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"44307_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12957-022-02697-w","volume":"20","author":"J Hu","year":"2022","unstructured":"Hu, J., Tian, C., Zhao, Y., Guo, Y. & Chen, S. Prognostic prediction of systemic immune-inflammation status for patie nts with colorectal cancer: a novel pyroptosis-related model. World J. Surg. Oncol. 20(1), 234 (2022).","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"44307_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","volume":"13","author":"R Tang","year":"2020","unstructured":"Tang, R. et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J. Hematol. Oncol. 13(1), 110 (2020).","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"44307_CR48","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","volume":"57","author":"M Ma","year":"2024","unstructured":"Ma, M., Jiang, W. & Zhou, R. DAMPs and DAMP-sensing receptors in inflammation and diseases. Immunity 57(4), 752\u2013771 (2024).","journal-title":"Immunity"},{"issue":"3","key":"44307_CR49","first-page":"397","volume":"1","author":"X Ke","year":"2025","unstructured":"Ke, X. et al. Cloud-based GWAS platform: An innovative solution for efficient acquisition and analysis of genomic data. Med. Res. 1(3), 397\u2013411 (2025).","journal-title":"Med. Res."},{"issue":"1","key":"44307_CR50","first-page":"10","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. Optimized dynamic network biomarker deciphers a high-resolution heterogeneity within thyroid cancer molecular subtypes. Med. Res. 1(1), 10\u201331 (2025).","journal-title":"Med. Res."},{"key":"44307_CR51","doi-asserted-by":"crossref","unstructured":"Zhang, P. et al. Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. J. Immunother. Cancer. 13(7), e012069. (2025).","DOI":"10.1136\/jitc-2025-012069"},{"issue":"1","key":"44307_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25(1), 25\u201329 (2000).","journal-title":"Nat. Genet."},{"issue":"1","key":"44307_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44307-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44307-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44307-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:49:08Z","timestamp":1789685348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44307-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44307"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44307-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Article in Press version of this Article contained errors in the Supplementary Information file where blots for \u2018BLK\u2019 and \u2018GAPDH\u2019 in Repeat 2 of the Supplementary Figure S8 were incorrect. The corrected Supplementary Information file now accompanies the Version of Record of the Article.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Xiangya Hospital, Central South University, China (2023030354). All experiments were conducted in accordance with the relevant guidelines and regulations. And this study is reported in compliance with the ARRIVE guidelines (\n                      \n                      ).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29080"}}